Skip to main content
NCBI home page
Brain Pathology logoLink to Brain Pathology
. 2008 Jan 28;7(2):765–784. doi: 10.1111/j.1750-3639.1997.tb01063.x

Primitive Neuroectodermal Tumors of the Central Nervous System

Lucy Balian Rorke 1,✉, John Q Trojanowski 2, Virginia MY Lee 2, Robert A Zimmerman 3, Leslie N Sutton 4, Jaclyn A Biegel 5, Joel W Goldwein 6, Roger J Packer 7
PMCID: PMC8098595  PMID: 9161728

Abstract

Controversial issues relating to the pathobiology and classification of central nervous system primitive neuroectodermal tumors (PNETs) have plagued neuropathologists for more than 70 years. Hypotheses advanced in the mid‐1920's have remained as fixed concepts in contemporary literature, largely consequent to repetitious support by a small number of neuropathologists despite a growing body of information discrediting these ideas from neuroembryologists, oncologists, neuroscien‐tists and pathologists.

Attention has largely focused upon PNETs arising in the cerebellum (commonly known as medul‐loblastomas [MBs]), because about 80% of central nervous system (CNS) PNETs originate in this site. It has been asserted that the 20% which do not are biologically different, although most individuals agree that the histological features of PNETs that occur in different sites throughout the CNS are indistinguishable from those growing in the cerebellum.

The historical aspects of this controversy are examined in the face of evidence that there is, in fact, a unique class of CNS tumors which should appropriately be regarded as primitive neuroectodermal in nature. Specifically, a number of different approaches to the problem have yielded data supporting this hypothesis. These approaches include the identification of patterns of expression among a variety of cellular antigens (demonstrated by the use of immunopathological techniques), molecular analyses of cell lines derived from these tumors, experimental production of PNETs and molecular genetic analyses.

Differences of opinion among surgeons, oncologists and radiotherapists are typically resolved by conducting cooperative studies of patients with these tumors who are diagnosed and treated at multiple centers.

Full Text

The Full Text of this article is available as a PDF (5.8 MB).

References

  • 1. Albrecht S., VonDeimling A., Pietsch T., Giangaspero F., Brandner S., Kleihues P., Wiestler OD (1994) Microsatellite analysis of loss of heterozygosity on chromosomes 9p, Up and 17p in medulloblastomas. Neuropath Appl Neurobiol 20: 74–81. [DOI] [PubMed] [Google Scholar]
  • 2. Albright AL, Wisoff JH, Zeltzer P., Boyett J., Rorke LB, Stanley P., Geyer JR, Milstein JM (1995) Prognostic factors in children with supratentorial (nonpineal) primitive neuroectodermal tumors. Pediatr Neurosurg 22: 1–7. [DOI] [PubMed] [Google Scholar]
  • 3. Allen JC, Epstein F. (1982) Medulloblastoma and other primary malignant neuroectodermal tumors of the CNS. The effect of patients' age and extent of disease on prognosis. J Neurosurg 57: 446–451. [DOI] [PubMed] [Google Scholar]
  • 4. Allen JC, Walker RW, Luks E. (1987) Carboplatin and recurrent childhood brain tumors. J Clin Oncol 5: 459–463. [DOI] [PubMed] [Google Scholar]
  • 5. Allen J., Nirenberg A., Donohue B. (1991) A phase I/II pilot study employing hyperfractionated radiotherapy and adjuvant chemotherapy for high‐risk primitive neuroectodermal tumors. Ann Neurol 30: 457–458. [Google Scholar]
  • 6. Ashley DM, Meier L., Kerby T., Zaldvondo FM, Friedman HS, Gajjar A., Kun L., Duffner PK, Smith S., Longee D. (1996) Response of recurrent medulloblastoma to low‐dose oral etoposide. J Clin Oncol 14: 1922–1927. [DOI] [PubMed] [Google Scholar]
  • 7. Baker DL, Molenaar WM, Trojanowski JQ, Evans AE, Ross AH, Rorke LB, Packer R., Lee VM‐Y, Pleasure D. (1991) Nerve growth factor receptor expression in peripheral and central primitive neuroectodermal tumors, other pediatric brain tumors and during development of the adrenal gland. Am J Pathol 139: 115–122. [PMC free article] [PubMed] [Google Scholar]
  • 8. Bailey OT (19851986) Genesis of the Percival Bailey‐Cushing classification of gliomas. Pediat Neurosci 12: 261–265. [DOI] [PubMed] [Google Scholar]
  • 9. Bailey P., Cushing H. (1925) Medullobastoma cerebelli. A common type of midcerebellar glioma of childhood. Arch Neurol Psychiat 14: 192–224. [Google Scholar]
  • 10. Bailey CC, Gnekow A., Wellek S., Jones M., Round C., Brown J., Phillips A., Neidhardt MK (1995) Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II. Med Ped Oncol 25: 166–178. [DOI] [PubMed] [Google Scholar]
  • 11. Baram TZ, van Eys JV, Dowell RE, Cangir A., Pack B., Bruner JM (1987) Survival and neurologic outcome of infants with medulloblastoma treated with surgery and MOPP chemotherapy; a preliminary report. Cancer 60: 173–177. [DOI] [PubMed] [Google Scholar]
  • 12. Barbacid M. (1995) Neurotrophic factors and their receptors. Curr Opin Cell Biol 7: 148–155. [DOI] [PubMed] [Google Scholar]
  • 13. Batra SK, McLendon RE, Koo JK, Castelino‐Prabhu S., Fuchs HE, Krischer JR Friedman HS, Bigner DD, Bigner SH (1995) Prognostic implication os chromosome 17p deletions in human medulloblastomas. J Neuro-Oncol 24: 39–45. [DOI] [PubMed] [Google Scholar]
  • 14. Becker LE (1989) Primitive neuroectodermal tumors: Views on a working classification. In: Primary Brain Tumors. A Review of Histologic Classification, Fields WS, (ed), Chapter 4, pp 59–69, Springer: New York . [Google Scholar]
  • 15. Becker LE, Hinton D. (1983) Primitive neuroectodermal tumors of the central nervous system. Human Pathol 14: 538–550. [DOI] [PubMed] [Google Scholar]
  • 16. Bertolone SJ, Baum ES, Krivit W., Hammond GD (1989) A phase II study of cisplatin therapy in recurrent childhood brain tumors. A Childrens Cancer Group Phase II trial. J Neuro-Oncol 7: 5–11. [DOI] [PubMed] [Google Scholar]
  • 17. Biegel JA, Rorke LB, Packer RJ, Sutton LN, Schut L., Bonner K., Emanuel BS (1989) Isochromosome 17q in primitive neuroectodermal tumors of the central nervous system. Gene Chrom Cancer 1: 139–147. [DOI] [PubMed] [Google Scholar]
  • 18. Biegel JA, Porke LB, Packer RJ, Emanuel BS (1990) Monosomy 22 in rhabdoid or atypical teratoid tumors of the brain. J Neurosurg 73: 710–714. [DOI] [PubMed] [Google Scholar]
  • 19. Biegel JA, Burk CD, Barr FG, Emanuel BS (1992) Evidence of a 17p tumor related locus distinct from p53 in pediatric central nervous system primitive neuroectodermal tumors. Cancer Res 52: 3391–3395. [PubMed] [Google Scholar]
  • 20. Biegel JA, Rorke, LB , Janss AJ, Sutton LN, Parmiter AH (1995) Isochromosome 17q demonstrated by interphase FISH in primitive neuroectodermal tumors of the central nervous system. Gene Chrom Cancer 14: 85–96. [DOI] [PubMed] [Google Scholar]
  • 21. Biegel JA, Wentz E. (1997) No preferential parent of origin for the isochromosome 17q in childhood primitive neuroectodermal tumor‐medulloblastoma. Gene Chrom Cancer (in press). [PubMed]
  • 22. Biegel JA, Janss AJ, Raffel C., Sutton L., Rorke LB, Harper JM, Phillips PC. (1997) Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system. Clin Can Pes (in press). [PubMed]
  • 23. Blaeker H., Rasheed BKA, McLendon RE, Friedman HS, Surinder K., Batra SK, Fuchs HE, Bigner SH (1996) Microsatellite analysis of childhood brain tumors. Gene Chrom Cancer 15: 54–63. [DOI] [PubMed] [Google Scholar]
  • 24. Boor R., Huber A., Gutjahr P. (1994) Etoposide treatment in recurrent medulloblastoma. Neuropediatrics 25: 39–41. [DOI] [PubMed] [Google Scholar]
  • 25. Bouffet E., Bernard JL, Frappaz D., Gentet JC, Roche H., Tron P., Carre C., Raybaud C., Joannard A., Lapras C., Choux M., Carton M., Almard L., Philip R., Brunat‐Mentigny M. (1992) M4 protocol for cerebellar medulloblastoma: Supratentorial radiotherapy may not be avoided. Int J Rad Oncol Biol Phys 24: 79–85. [DOI] [PubMed] [Google Scholar]
  • 26. Brand WN, Schneider PA. Tokars RP (1987) Long term results of a pilot study of low dose craniospinal irradiation for cerebellar medulloblastoma. Int J Rad Oncol Biol Phys 13:1641–1645. [DOI] [PubMed] [Google Scholar]
  • 27. Cattaneo E., McKay R. (1990) Proliferation and differentiation of neuronal stem cells regulated by nerve growth factor. Nature 347: 762–765. [DOI] [PubMed] [Google Scholar]
  • 28. Chambers EF, Turski PA, Sobel D., Wara W., Newton TH (1981) Radiologic characteristics of primary cerebral neuroblastomas. Radiology 139: 101–104. [DOI] [PubMed] [Google Scholar]
  • 29. Chao MV, Hempstead BL (1995) p75 and Trk: A two receptor system. TINS 7: 321–326. [PubMed] [Google Scholar]
  • 30. Chao MV, Bothwell MA, Ross AH, Koprowski H., Lanahan AA, Buck CR Sehgal A. (1986) Gene transfer and molecular cloning of the human NGF receptor. Science 232: 518–521. [DOI] [PubMed] [Google Scholar]
  • 31. Chung R., Whaley J., Kley N., Anderson K., Louis D., Menon A., Heetich C., Freiman R., Hedley‐Whyte ET, Martuza R., Jenkirs R., Yandell D., Seizinger BR (1991) Gene Chrom Cancer 3: 323–331. [DOI] [PubMed] [Google Scholar]
  • 32. Cogen PH, McDonald JD (1996) Tumor suppressor genes and medulloblastoma. J Neuro-Oncol 29: 103–112. [DOI] [PubMed] [Google Scholar]
  • 33. Cordon‐Cardo C., Tapley P., Jing SQ, Nanduri V., O'Rourke E., Lamballe F., Kovary K., Klein R., Jones KR, Reichardt LF, Barbacid M. (1991) The trk tyrosine protein kinase mediates the mitogenic properties of nerve growth factor and neurotrophin‐3. Cell 66: 173–183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Cushing H. (193031) Experiences with the cerebellar medulloblastomas. A critical review. Acta path et microbial Scand 7–8: 1–86. [Google Scholar]
  • 35. Deckwertn T., Johnson EM (1993) Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor. J Cell Biol 123: 1207–1222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Deutsch M., Thomas PR, Krischer J., Boyett J. Albright L., Aronin P., Langston J., Allen JC, Packer RJ, Lingsgood R., Muihern R., Stanley P., Stehbens JA, Duffner P., Kun L., Rorke, LB , Cherlow U., Freidman H., Finlay JL, Vietti T. (1996) Results of prospective randomized trial comparing standard dose neuraxis irradiation (3,600 cGy/20) with reduced neuraxis irradiation (2,340 cGy/13) in patients with low‐stage medulloblastoma: a combined Chiidrens Career Group‐Pediatric Oncology Group study. Pediat Neurosurg 24: 167–177. [DOI] [PubMed] [Google Scholar]
  • 37. Doupe AJ, Landis SC, Patterson PH (1985) Environmental influence in the development of neural crest derivatives: glucocorticoids, growth factors and chromaffin cell plasticity. J Neurosci 5: 2119–2142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Duffner PK, Horowitz ME, Krischer JP, Friedman HS, Burger PC, Cohen ME, Sanford RA, Mulhem RK, James HE, Freeman CR (1993) Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Eng J Med 328: 1725–1731. [DOI] [PubMed] [Google Scholar]
  • 39. Dupuis‐Girod S., Hartmann O., Benmhamou E., Doz F, Mechinaud , Bouffet E., Coze C., Kalifa C. (1996) Will high‐dose chemotherapy followed by autologous bone marrow transplantation supplant cranio‐spinal irradiation, in young children treated for medullcblastoma J Neuro-Oncol 27: 87–98. [DOI] [PubMed] [Google Scholar]
  • 40. Eibl RH, Kleihues P., Jat PS Wiestler OD (1994) A model for primitive neuroectodermal tumors in transgenic neural transplants harboring the SV40 large T antigen. Am J Pathol 144: 556–564. [PMC free article] [PubMed] [Google Scholar]
  • 41. Evans AE, Jenkin RD, Sposto R., Ortega JA, Wilson CB, Wara W., Ertel IJ, Kramer S., Chang CH, Leikin SL (1990) The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg 72: 572–582. [DOI] [PubMed] [Google Scholar]
  • 42. Felix CA, Save I., Dunn M., Strauss EA, Biegel JA (1995) Germline and somatic p53 gene mutations in pediatric brain tumors. MPO 25: 431–436. [DOI] [PubMed] [Google Scholar]
  • 43. Finlay JL, Goidman S., Wong MC, Cairo M., Garvin J., August C., Cohen BH, Stanley P., Zimmerman RA, Bostrom B. (1997) Pilot study of high‐dose Thiotepa and etoposide with autologous bone marrow rescue In children and young adults with recurrent CNS tumors. J Clin Oncol (in press). [DOI] [PubMed]
  • 44. Finlay JL, Garvin J., Allen JC, Boyett J., Heber G., Yates A., Rosenblum M., Geyer J., Lindsley K., Goldman S., Sander L., Cowan M., Jennings M., Harris R., Bostrom B., Sanders J. (1994) High‐dose chemotherapy with autologous marrow rescue (ABMR) in patients with recurrent medulloblastoma/PNET. Proc Am Soc Clin Oncol 13: 176. [Google Scholar]
  • 45. Finlay JL (1996) The “head start” regimen for children less than 6 years of age newly‐diagnosed with malignant brain tumors. J Neuro-Oncol 28: 68. [Google Scholar]
  • 46. Frade J‐M, Rodriguez‐Tebar A., Barde Y‐A (1996) Induction of cell death by endogenous nerve growth factor through its p75 receptor. Nature 383: 166–168. [DOI] [PubMed] [Google Scholar]
  • 47. Friedman HS, Krischer JP, Burger P., Oakes WJ, Hockenberger B., Weiner MD, Falletta JM, Norris D., Ragab AH, Mahoney DH Jr, Whitehead MV, Kun LE (1992) Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II trial. J Clin Oncer 10: 249–256. [DOI] [PubMed] [Google Scholar]
  • 48. Fung K‐M, Chikaralshi DM, Messng A., Albert DM, Lee VM‐Y, (1994) Molecular phenotype of Simian virus 40 large T antigen‐induced primitive neuroectodermal tumors in four different lines of transgenic mice. Lab Invest 70: 114–124. [PubMed] [Google Scholar]
  • 49. Fung K‐M, Trojanowski JQ (1995) Anima models of medulloblastomas and related primitive neuroectodermal tumors A review. J Neuropath Exp Neurol 54; 285–296. [DOI] [PubMed] [Google Scholar]
  • 50. Gaynon PS, Ettinger LJ, Baum ES, Siegel SE, Krailo MD, Hammond GD (1990) Carboplatin in childhood brain tumors. A Childrens Cancer Group phase II trial. Cancer 66: 2465–2469. [DOI] [PubMed] [Google Scholar]
  • 51. Geyer JR, Zelzer P., Boyett J., Rorke L., Stanley P., Apright L., Wisoff J., Milstein J., Allen J., Finlay J., Ayers G., Stevens K., Bleyer WA (1994) Survival of Infants with primitive neuroectodermal tumors of malignant ependymomas of the CNS treated with eight drugs in 1 day: A report from the Chiidrens Cancer Group. J Clin Oncol 12: 1607–1615. [DOI] [PubMed] [Google Scholar]
  • 52. Goldwein JW, Radelife J., Johnson J., Moshang T., Packer RJ, Sutton LN, Rorke LB, D'Angio GJ (1996) Updated resuits of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulleblastoma). Int J Rad Oncol Biol Phys 34: 899–904. [DOI] [PubMed] [Google Scholar]
  • 53. Gould VE, Jansson OS, Molennar WM, Rorke B., Trojanowski JQ, Lee VM‐M, Packer RJ, Franke WW (1990) Primitive neuroectodermal tumors of the central nervous system. Lab Invest 62: 498–509. [PubMed] [Google Scholar]
  • 54. Gould VE, Rorke LB, Jansson Ds, Molenaar WM, Trojanowski JQ, Lee VM‐M Packer RJ, Franke WW (1990) Primitive neuroectodermal tumors of the central nervous system express neuroendocrine markers and may express all classes of intermediate filaments. Human Pathol 21: 245–252. [DOI] [PubMed] [Google Scholar]
  • 55. Gullotta F. (1967) Die sogenannten medullobiastom. Mongraphic aus dem Gesamtgebiete der Neurologie und Psychiatrie, Heft 188, Springer; Berlin . [Google Scholar]
  • 56. Hahn H., Wicking C., Zaphiropoulous PG, Gailani MR, Shanley S., Chidambaram A., Vorechovsky I., Holmberg E., Unden AB, Gillies S., Negus K., Smuth I., Pressman C., Leffell DJ, Gerrard B., Godlstein AM, Dean M., Toftgard R., Chenenvix‐Trench G., Wainwright B., Bale AE (1996) Mutations of the human hemolog of Drosophilia patched in the nevoid basal cell carcinoma syndrome. Cell 85: 841–851. [DOI] [PubMed] [Google Scholar]
  • 57. Halberg FE, Wara WM, Fippn LF, Edwards MSB, Levin VA, Davis RL, Prados MB, Wilson CB (1991) Low‐dose craniospinal radiation for meduloblastoma. Int J Rad Oncol Physiol 20: 651–654. [DOI] [PubMed] [Google Scholar]
  • 58. Halperin EC (1993) Concerning the inferior portion of the spinal radiotherapy field for malignancies that disseminate via the cerebrospinal fluid. Int J Pad Oncol Physiol 26: 357–362. [DOI] [PubMed] [Google Scholar]
  • 59. Hamilton SR, Liu B., Parsons RE, Papadopoalos N., Jen J., Powell SM, Krush AJ, Berk T., Cohen Z., Tetu B., Burger PC, Wood PA, Taq F., Booker SV, Peterson GM, Offerhause GJA, Tersmette AC, Giardiello FM, Vogelstein B., Kinler KW (1995) The molecular basis of Turcotis syndrome. N Eng J Med 332: 839–847. [DOI] [PubMed] [Google Scholar]
  • 60. Hart MN, Earle KM (1973) Primitive neuroectodermal tumors of the brain in children. Cancer 32: 890–897. [DOI] [PubMed] [Google Scholar]
  • 61. Hempstead BL, Rabin SJ, Kapian L., Reid S., Parada LF, Kaplan DR (1992) Overexpression of the trk tyrosine kinase rapidiy accelerates nerve gmwth factor‐rcuced differentiation. Neuron 9: 883–896. [DOI] [PubMed] [Google Scholar]
  • 62. Henkemeyer M., Rossi DJ, Holmyard DP, Puri MC, Mbamalu G., Harpal K., Shih TS, Jacks T., Pawson T. (1995) Vascular system defects and neuronal apoptosis in mice lacking ras GTPase‐activating protein. Nature 377: 695–701. [DOI] [PubMed] [Google Scholar]
  • 63. Herpers MJHM, Budka H. (1985) Primitive neuroectodermal tumors including the medulloblastoma: glial differentiation signaled by immunoreactivity for GFAP is restricted to the pure desmoplastic medulloblastoma (“arachnoidal sarcoma of the cerebellum”). Clin Neuropath 4: 12–18. [PubMed] [Google Scholar]
  • 64. Hershatter BW, Halperin EC, Cox EB (1982) Medulloblastoma: The Duke University Medical Center experience. Int J Rad Oncol Biol Phys 12: 1771–1777. [DOI] [PubMed] [Google Scholar]
  • 65. Hughes E., Shillito J., Sallan SE, Loeffler JS, Cassady JR, Tarbell NJ (1988) Medulloblastoma at the Joint Center for Radiation Therapy between 1968 and 1984. Cancer 61: 1992–1998. [DOI] [PubMed] [Google Scholar]
  • 66. Ip NY, Stitt TN, Tapley P., Klein R., Glass DJ, Fandl J., Greene LA, Barbacid M., Yancopoulos GD (1993) Similarities and differences in the way neurotrophins interact with the Trk receptors in neuronal and non‐neuronal cells. Neuron 10: 137–149. [DOI] [PubMed] [Google Scholar]
  • 67. Jaffey PB, To GT, Xu H‐J, Hu S‐X, Benedict WF, Donaso LA, Campbell GA (1995) Retinoblastoma‐like phenotype expressed in medulloblastoma. J Neuropath Exp Neurol 54: 664–672. [DOI] [PubMed] [Google Scholar]
  • 68. James CD, He J., Carlborn E., Mikkelsen T., Ridderheim P‐A, Cavenee WK, Collins VP (1990) Loss of genetic information in central nervous system tumors common to children and young adults. Gene Chrom Cancer 2: 94–102. [DOI] [PubMed] [Google Scholar]
  • 69. Jänisch W., Schroeder G. (1977) Experimental Tumors of the Central Nervous System, First English Edition, Signer DH, Swenberg JA (eds). Upjohn Company: Kalamazoo . [Google Scholar]
  • 70. Janss AJ, Yachnis AT, Silber JH, Trojanowski JQ, Lee VM‐Y, Sutton LN, Perilongo G., Rorke LB, Phillips PC (1996) Glial differentiation predicts poor clinical outcome in primitive neuroectodermal tumors. Ann Neurol 39: 481–489. [DOI] [PubMed] [Google Scholar]
  • 71. Jereb B., Reid A., Rajender KA (1982) Patterns of failure with medulloblastoma. Cancer 50: 2941–2947. [DOI] [PubMed] [Google Scholar]
  • 72. Johnson D., Lanahan A., Buck CR, Sehgal A., Morgan C., Mercer E., Bothwell M., Chao MV (1986) Expression and structure and the human NGF receptor. Cell 47: 545–554. [DOI] [PubMed] [Google Scholar]
  • 73. Johnson DL, McCabe MA, Nicholson HS, Joseph AL, Getson PR, Byrne J., Brasseux C., Packer RJ, Reaman G. (1994) Quality of long‐term survival in young children with medulloblastoma. J Neurosurg 80: 1004–1010. [DOI] [PubMed] [Google Scholar]
  • 74. Johnson RL, Rothman AL, Xie J., Goodrich LV, Bare JW, Bonifas JM, Quinn AG, Myers RM, Cox DR, Epstein EH Hr, Scott MP (1996) Human homolog of patched, a candidate gene for basal cell nevus syndrome. Science 272: 1668–1671. [DOI] [PubMed] [Google Scholar]
  • 75. Kao G., Goldwein J., Schultz D., Radcliffe J., Sutton L., Lange B. (1994) The impact of perioperative factors on subsequent intelligence quotient deficits in children treated for medulloblastoma/posterior fossa neuroectodermal tumors. Cancer 74: 865–971. [DOI] [PubMed] [Google Scholar]
  • 76. Kallioniemi A., Kallioniemi O‐P, Sudr D., Rutovitz D., Gray JW, Waldman F., Pinkel D. (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258: 818–821. [DOI] [PubMed] [Google Scholar]
  • 77. Kaplan DR, Hempstead BL, Martin‐Zanca D., Chao MV, Parada LF (1991a) The trk proto‐oncogene product: a signal transducing receptor for nerve growth factor. Science 252: 554–558. [DOI] [PubMed] [Google Scholar]
  • 78. Kaplan DR, Martin‐Zanca D., Parada LF (1991b) Tyrosine phosphorylation and tyrosine kinase activityof the trk proto‐oncogene product induced by NGF. Nature 350: 158–160. [DOI] [PubMed] [Google Scholar]
  • 79. Kaplan DR, Stephens RM (1994) Neurotrophin signal transduction by the Trk receptor. J Neurobiol 25: 1404–1417. [DOI] [PubMed] [Google Scholar]
  • 80. Kershman J. (1938) The medulloblast and the medulloblastoma. A study of human embryos. Arch Neurol Psychiat 40: 937–967. [Google Scholar]
  • 81. Kersting G. (1961) Die Gewebszüchtung menschlicher Hirngeschwulste. Springer: Berlin . [Google Scholar]
  • 82. Kleihues P., Burger PC, Scheithauer BW (1993) Histological Typing of Tumors of the Central Nervous System, Springer: New York . [Google Scholar]
  • 83. Klein R., Jing SQ, Nanduri V., O'Rourke E., Barbacid M. (1991a) The trk proto‐oncogene encodes a receptor for nerve growth factor. Cell 65: 189–197. [DOI] [PubMed] [Google Scholar]
  • 84. Klein R., Nanduri V., Jing S., Lamballe, Tapley P., Bryant S., Cordon‐Cardo C., Jones KR, Reichardt LF, Barbacid M. (1991b) The trkB tyrosine protein kinase is a receptor for brain‐derived neurotrophic factor and neurotrophin‐3. Cell 66: 395–403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85. Kleinert R. (1991a) Immunohistochemical characterization of primitive neuroectodermal tumors and their possible relationship to the stepwise ontogenetic development of the central nervous system. 1. Ontogenetic studies. Acta Neuropathol 82: 302–307. [DOI] [PubMed] [Google Scholar]
  • 86. Kleinert R. (1991b) Immunohistochemical characterization of primitive neuroectodermal tumors and their possible relationship to the stepwise ontogenetic development of the central nervous system. 2. Tumor studies. Acta Neuropathol 82: 308–313. [DOI] [PubMed] [Google Scholar]
  • 87. Koch A., Tonr J., Kraus JA, Sorensen N., Albrecht S., Wiestler OD, Pietsch T. (1996) Molecular analysis of the lissencephaly gene 1 (LIS‐1) in medulloblastomas. Neuropath Appl Neurobiol 22: 233–242. [PubMed] [Google Scholar]
  • 88. Korf H‐W, Goetz W., Herken R., Theuring F., Gruss P., Schachenmayr W. (1990) S‐antigen and rod‐opsin immunoreactions in midline brain neoplasms of transgenic mice: Similarities to pineal cell tumors and certain medulloblastomas in man. J Neuropathol Exp Neurol 49: 424–437. [DOI] [PubMed] [Google Scholar]
  • 89. Korf H‐W, Korf B., Schachenmayr W., Chader GJ, Wiggert B. (1992) Imrrunocytochemical demonstration of inter‐photorecepto retinoid‐binding protein in cerebellar medulloblastoma. Acta Neuropathol 83: 482–487. [DOI] [PubMed] [Google Scholar]
  • 90. Kozmik Z., Sure U., Ruedi D., Busslinger M., Aguzzi A. (1995) Absence of p53 mutations in childhood central nervous system primitive neuroectodermal tumors. Neurosurgery 33: 301–306. [DOI] [PubMed] [Google Scholar]
  • 91. Kovnar ‐EH, Kellie SJ, Horowitz ME, Sanford RA, Langston JW, Mulhern RK, Jenkins JJ, Douglass EC, Etcubanas EE, Fairclough DL, Kun LE (1990) Preirradiation cisplatin and etoposide in the treatment of high‐risk medulloblastoma and other malignant embryonal tumors of the central nervous system: a phase II study. J Clin Oncol 8: 330–336. [DOI] [PubMed] [Google Scholar]
  • 92. Krischer JP, Ragab AH, Kun L., Kim TH, Laurent JP, Boyett JM, Cornell CJ, Link M., Luthy AR, Camitta B. (1991) Nitrogen mustard vincristine, procarbazine, and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg 74: 905–909. [DOI] [PubMed] [Google Scholar]
  • 93. Lamballe F., Klein R., Barbacid M. (1991) trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neutrophin‐3. Cell 66: 967–679. [DOI] [PubMed] [Google Scholar]
  • 94. Lardberg TC, Linagren ML, Cavallin‐Stahi E.K, Svahn‐Tapper GO, Sundbarg G., Garwicz S., Lagergren JA, Gunnesson VL, Brun AE, Cronquist SE (1980) Irrproved radiotherapy of medulloblastoma, 1946–1975. Cancer 45: 670–678. [DOI] [PubMed] [Google Scholar]
  • 95. Levi‐Montalcini R., Angeletti P. (1968) Nerve growth facton Physiol Rev 48: 534–569. [DOI] [PubMed] [Google Scholar]
  • 96. Levin VA, Rodriguez LA, Edwards MSB, Wara W., Liu H., Fulton D., Davis RL, Wilson CB, Silver P. (1988) Treatment of medulloblastoma with procarbazine, hydroxyurea, and reduced radiation doses to whole brain and spine. J Neurosurg 68: 383–387. [DOI] [PubMed] [Google Scholar]
  • 97. Li BQ, Kaplan DR, Kung HF, Kamata T. (1992) Nerve growth factor stimulation of the Ras‐guanine nucleotide exchange factor and GAP activities. Science 256: 1456–1459. [DOI] [PubMed] [Google Scholar]
  • 98. Li Y., Holtman DM, Kramer LF, Kaplan DR, Chua‐Couzens J., Clary DO, Knusel B., Mobley WB (1995) Regulation of TrkA and ChAT expression in developing rat basal fore‐brain: Evidence that both exogenous and endogenous NGF regulate differentiation of cholinergic neurons. J Neurosci 15: 2888–2905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99. Lillian L., Claude P. (1985) Nerve growth factor is a mitogen for cultured chromaffin cells. Nature 317: 632–634. [DOI] [PubMed] [Google Scholar]
  • 100. Lindsay RM, Wiegand SJ, Altar CA, DiStefano PS (1994) Neurotrophic factors: from molecule to man. TINS 17: 182–190. [DOI] [PubMed] [Google Scholar]
  • 101. Louis DN, VonDiemling A. (1995) Hereditary tumor syndromes of the nervous system: Overview and rare syndromes. Brain Paihol 5: 145–151. [DOI] [PubMed] [Google Scholar]
  • 102. Molntosh S., Chen M., Sartain PA, Duncan C., Fishburn R., Klatskin EM, Schwartz AD, Venes JL (1985) Adjuvant chemotherapy for medulloblastoma. Cancer 56: 1316–1319. [DOI] [PubMed] [Google Scholar]
  • 103. Meyers SP, Kemp SS, Tarr RW (1992) MR imaging features of medullobiastomas. Am J Roentgenol 158: 859–865. [DOI] [PubMed] [Google Scholar]
  • 104. Otten U., Valletta JS, Johnston MV (1989) Developmental regulation of nerve growth factor and its receptor in the rat caudate putamen. Neuron 3: 655–664. [DOI] [PubMed] [Google Scholar]
  • 105. Moghrabi A., Fuchs H., Brown M., Schold SC Jr, Graham M., Kurtzberg J., Tien R., Felsberg G., Lachane DH, Colvin OM, Oette D., Allegretta GJ, Hockenberger B., Stewart E., Ferrell L., Kerby T., Duncan‐Brown M., Bigner DD, Friedman HS (1995) Cycloohosophamide in combination with sagramostim in the treatment of recurrent medulloblastoma. Med Pediatr Oncol 25: 190–196. [DOI] [PubMed] [Google Scholar]
  • 106. Molenaar WN, Jansson DS, Gould VE, Rorke LB, Franke WW, Lee VM‐Y, Packer RJ, Trojanowski JQ (1989) Molecular markers of primitive neuroectodermal tumors and other pediatric central nervous system tumors. Monoclonal antibodies to neuronal and glial antigens distinguish subsets of primitive neuroectodermal tumors. Lab Invest 61: 635–643. [PubMed] [Google Scholar]
  • 107. Molenaar WM, Rorke LB, Trojanowski JQ (1993) Neural tumors. In: Diagnostic Immunopathology, Calvin RB, Bran AK, McCluskey RT (eds.), Second Edition, Chapter 34, op. 651–668, Raven Press: New York , NY . [Google Scholar]
  • 108. Molenaar WM, Baker DL, Pleasure D., Lee VM‐Y, Trojanowski JQ (1990) The neuroendocrine and neural profiles of neuroblastomas, ganglioneurobiastomas and ganglioneuramas. Am J Pathol 136: 375–382. [PMC free article] [PubMed] [Google Scholar]
  • 109. Muragaki Y., Chou TT, Trojanowski JQ, Lee VM‐Y (1997) Nerve growth factor Induces apoptosis in human medulloblastorra cell lines that express TrkA receptors. J Neurosci (in press). [DOI] [PMC free article] [PubMed]
  • 110. Nakagawara A., Arima M., Azar CG, Scavarda NJ, Brodcur GM (1992) Inverse relationship between trk expressior and N‐myc amplification, n human neuroblastcmas Cancer Res 52: 1364–1368. [PubMed] [Google Scholar]
  • 111. Nakagawara A., Arima‐Nakagawara M., Scavarda N., Azar CG, Cantor AB, Brodeur GM (1993) Association between high levels of expression of the trk gene and favorable outcome in human neuroblastoma. New Eng J Med 328: 847–854. [DOI] [PubMed] [Google Scholar]
  • 112. Nelson M., Diebler C., Forbes WStC (1991) Paeciatric medulloblastoma: Atypical CT features of presentation in the SIOP II trial. Neuroradiology 33: 140–142. [DOI] [PubMed] [Google Scholar]
  • 113. North C., Segall HD, Stanley P., Zee CS, Ahmadi J., McComb JG (1995) Early CT detection of intracranial seeding from medulloblastoma. AJNR 6: 11–13. [PMC free article] [PubMed] [Google Scholar]
  • 114. Packer RJ (1990) Chemotherapy for medulloblastoma/primitive neuroectodermal tumors of the posterior fossa Ann Neurol 28: 823–828. [DOI] [PubMed] [Google Scholar]
  • 115. Packer RJ, Sutton LN, AtKins TE, Radoliffe J., D'Angio GJ, Siegel KR, Schut L. (1989) A prospective study of cognitive function in patients receiving whole‐brain radiotherapy and chemotherapy: 2‐year results. J Neurosurg 70: 707–713. [DOI] [PubMed] [Google Scholar]
  • 116. Packer RJ, Sutton LN, Elterman R., Lange B., Goldwer J., Nicholson HS, Mulne L., Boyett J., D'Angio G., Wechsder‐Jentzsch K. (1994) Outcome for children with medulloblastorra treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg 81: 690–698. [DOI] [PubMed] [Google Scholar]
  • 117. Packer RJ, Deutsch M., Thomas PRM, Boyett J., Kun L., Friedman H. (1996) What constitutes standard therapy for children older than 3 years of age with non‐disseminated medulloblastoma. Ann Neurol 40: 292–298. [Google Scholar]
  • 118. Packer RJ, Sutton LN, Rorke LB, Littman PA, Sposto R., Rosenstock JG, Bruce DA, Schut L. (1984) Prognostic significance of cellular differentiation in medulloblastoma of childhood. J Neurosurg 61: 296–301. [DOI] [PubMed] [Google Scholar]
  • 119. Peringa J., Fung K‐M, Muragaki Y., Trojanowski JQ (1995) The cellular and molecular biopsy of medulloblastoma. Curr Opin Neurol 8: 437–440. [DOI] [PubMed] [Google Scholar]
  • 120. Pfleger MJ, Gerson LP (1993) Supratentorial turners in children. Neuroimaging Clin N Amer 3: 671–687. [Google Scholar]
  • 121. Pleasure SJ, Reddy UR, Venkatakrishnan G., Roy AK. Chen J., Ross AH, Trojanowski JQ, Pleasure DE, Lee VM‐Y (1990) Introduction of nerve growth factor (NGF) receptors into a medulloblastoma cell line results in expression of high‐and low‐affinity NGF receptors but not NGF‐mediated differentiation. Proc Natl Acad Sci USA 87: 8496–8500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 122. Polak M. (1967) On the true nature of the so called medulloblastoma. Acta Neuropathoi (Berl) 8: 84–95. [DOI] [PubMed] [Google Scholar]
  • 123. Radeke MJ, Misko TP, Hsu C., Herzenberg LA, Shooter EM (1987) Gene transfer and molecular coning of the rat nerve growth factor receptor. Nature 325: 593–597. [DOI] [PubMed] [Google Scholar]
  • 124. Raffel C., Thomas GA, Tishler DM, Lassoff S., Allen JC (1993) Absence of p53 mutations in childhood central nervous system primitive neuroectodermal tutors. Neurosurgery 33: 301–306. [DOI] [PubMed] [Google Scholar]
  • 125. Rorke LB (1983) The cerebellar medulloblastoma and its relationship to primitive neuroectodermal tumors. J Neuropathol Exp Neurol 42: 1–15. [PubMed] [Google Scholar]
  • 126. Rorke LB, Giles FF, Davis R., Becker L. (1985) Revision of the World Health Organization classification of brain tumors for childhood brain tumors. Cancer 56 (suoplement): 1869–1886. [DOI] [PubMed] [Google Scholar]
  • 127. Rorke LB (1989) Primitive neuroectodermal tumer—a concent redirng an apologia? Int Primary Brain Tumors: A Review of Histological Classification, Fields WS (ed) Chapter 1, pp. 5–15, Springer: New York . [Google Scholar]
  • 128. Rorke LB (1994) Commentary‐ Experimental production of primitive neuroectodermal tumors and its relevance to human neuro‐oncology. Am J Path 144: 444–448. [PMC free article] [PubMed] [Google Scholar]
  • 129. Rubinstein LJ (1972) Cytogenesis and differentiation of primitive central neuroepithelial tumors. J Neuropathol Exp Neurol 31: 7–26. [DOI] [PubMed] [Google Scholar]
  • 130. Rubinstein LJ (1975) The cerebellar medulloblastoma: Its origin, differentiation, morphological variants, and biological behavior. In: Tumors of the Brain and Skull, Vincken PJ, Bruyn GW (eds.), Part III, Chapter 9, pp. 167–193, Elsevier: New York , NY . [Google Scholar]
  • 131. Rubinstein LJ (1985) A commentary on the proposed revision of the World Health Organization c assification of brain tumors for childhood tumors. Cancer 56 (Suppl): 1887–1888. [DOI] [PubMed] [Google Scholar]
  • 132. Rubinstein LJ (1989) Justification for a cytogenetic scheme of embryonal central neuroepithelial tumors. In: Primary Brain Tumors: A Review, of Histological Classification, Fields WS (Ed.) Chapter 2, pp. 16–27, Springer: New York , NY . [Google Scholar]
  • 133. Russell DS, Rubinstein LJ (1989) Pathology of Tumours of the Nervous System, Fifth Edition, Williams & Wilkins: Baltimore , MD . [Google Scholar]
  • 134. Sandhu A., Kendall B. (1987) Computed tomography in management of medulloblastomas. Neuroradiology 29: 444–452. [DOI] [PubMed] [Google Scholar]
  • 135. Saylors RL, Sidransky D., Friedman HS, Bigner SH, Bigner DD, Vogelstein B., Brodeur GM (1991) Infrequent p53 gene mutations in medulloblastomas. Cancer Res 51: 4721–4723. [PubMed] [Google Scholar]
  • 136. Scheurlen W., Sorensen N., Roggendorf W., Kuhl J. (1996) Molecular analysis of medulloblastomas occurring simultaneously in monozygotic twins. E J Pediatr 155: 880–884. [DOI] [PubMed] [Google Scholar]
  • 137. Scheurlen WG, Krauss J., Kuhl J. (1995) No preferential‐loss of one parental allele of chromosome 17p13.3 in childhood medulloblastoma. Int J Cancer 63: 373–374. [DOI] [PubMed] [Google Scholar]
  • 138. Schiffer D., Cavalla P., Chio A., Giordana MT, Marino S., Mauro A., Migheli A. (1994) Tumor cell proliferation and apoptosis in medulloblastoma. Acta Neuropathol 87: 362–370. [DOI] [PubMed] [Google Scholar]
  • 139. Schutz BR, Scheurlen W., Krauss J., DuManoir S., Joos S., Bentz M., Lichter P. (1996) Mapping of chromosomal gains and losses in primitive neuroectodermal tumors by comparative genomic hybridization. Gene Chrom Cancer 16: 196–203. [DOI] [PubMed] [Google Scholar]
  • 140. Segal RA, Goumnerova LC, Kwon YK, Stiles CD, Pomeroy S.L. (1994) Expression of the neurotrophin receptor Trk C is linked to a favorable outcome in medulloblastoma. Proc Natl Acad Sci USA 91:12867–12871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 141. Segal RA, Takahashi H., McKay RDG (1992) Changes in neurotrophin responsiveness during the development of cerebellar granule neurons. Neuron 9: 1041–1052. [DOI] [PubMed] [Google Scholar]
  • 142. Slavic I., Rodriguez IR, Mazuruk K., Cahder GJ, Biegel J. (1995) LOH detected by single strand conformation polymorphism analysis of PEDF in CNS primitive neuroectodermal tumors. Med Pediatr Oncol 25: P174. [Google Scholar]
  • 143. Solit DB, Goldwein JW (1995) Posterior fossa: Analysis of a popular technique for estimating the location in children with medulloblastoma. Radiology 195: 697–698. [DOI] [PubMed] [Google Scholar]
  • 144. Tait DM, Thornton‐Jones H., Blood JL, Morris‐Jones P. (1990) Adjuvant chemotherapy for medulloblastoma: the first multi‐centre control trial of the International Society of Paediatric Oncology (SIOP I). Eur J Cancer 26: 464–469. [PubMed] [Google Scholar]
  • 145. Tischler AS, Riseberg JC, Hardenbrook MA, Cherington V. (1993) Nerve growth factor is a potent inducer of proliferation and neuronal differentiation for adult rat chromaffin cells in vitro. J Neurosci 13: 1533–1542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 146. Tola JS (1951) The histopathological and histological characteristics of the primary neoplasms of the cerebellum and the fourth ventricle. Acta Chirurgica Scand, Suppl 164: 1–112. [PubMed] [Google Scholar]
  • 147. Tremblay GF, Lee VM‐Y, Trojanowski JQ (1985) Expression of vimentin, glial filament and neurofilament in primitive childhood brain tumors. A comparative immunoblot and immunoperoxidase study. Acta Neuropathol 68: 239–244. [DOI] [PubMed] [Google Scholar]
  • 148. Trojanowski JQ (1987) Neurofilament proteins and human nervous system tumors. J Histochem Cytochem 35: 999–1003. [DOI] [PubMed] [Google Scholar]
  • 149. Trojanowski JQ, Tohyama T., Lee VM‐Y (1992) Medulloblastomas and related primitive neuroectodermal tumors of childhood recapitulate molecular milestones in the maturation of neuroblasts. Mol Chem Neuropathol 17: 121–135. [DOI] [PubMed] [Google Scholar]
  • 150. Trojanowski JQ, Fung K‐M, Rorke LB, Tohyama T., Yachnis AT, Lee VM‐Y (1994) In vivo and in vitro models of medulloblastomas and other primitive neuroectodermal brain tumors of childhood. Mol Chem Neuropathol 21: 219–239. [DOI] [PubMed] [Google Scholar]
  • 151. Vagner‐Capodano AM, Genter JC, Choux M., Lena G., Garbarel D., Bernard JL, Raybaud C. (1989) Chromosomal abnormalities in 16 pediatric brain tumors. Pediatr Neurosci 14: 150–160. [Google Scholar]
  • 152. Walker RW, Allen JC (1988) Cisplatin in the treatment of recurrent childhood primary brain tumors. J Clin Oncol 6: 62–66. [DOI] [PubMed] [Google Scholar]
  • 153. Weil MD (1994) Pattern of recurrence of medulloblastoma after low‐dose‐craniospinal radiotherapy. Int J Rad Oncol Biol Phys 30: 551–556. [DOI] [PubMed] [Google Scholar]
  • 154. Washiyama K., Muragaki Y., Rorke LB, Lee VM‐Y, Feinstein SC, Radeke MJ, Blumberg D., Kaplan DR, Trojanowski JQ (1996) Neurotrophin and neurotrophin receptor proteins in medulloblastomas and other primitive neuroectodermal tumors of the pediatric central nervous system. Am J Pathol 148: 929–940. [PMC free article] [PubMed] [Google Scholar]
  • 155. Wood W., Sarnecki C., Roberts TM, Blenis J. (1992) ras mediates nerve growth factor receptor modulation of three signal‐transducing protein kinases: MAP kinases, Raf‐1, and RSK. Cell 68: 1041–1050. [DOI] [PubMed] [Google Scholar]
  • 156. Yachnis AT, Rorke LB, Trojanowski JQ (1994) Cerebellar dysplasias in humans: development and possible relationship to glial and primitive neuroectodermal tumors of the cerebellar vermis. J Neuropathol Exp Neurol 53: 61–71. [DOI] [PubMed] [Google Scholar]
  • 157. Zee CS, Segall HD, Nelson M., Destian S., Ahmadi J. (1993) Infratentorial tumors in children. Neuroimag Clin N Am 3: 705–714. [Google Scholar]
  • 158. Zeltzer P., Boyett J., Finlay JL, Albright L., Wisoff J., Geyer R., McGuire‐Cullen P., Rorke LB, Stevens K., Shurin S., Milstein J., Packer RJ (1995) Tumor staging at diagnosis and therapy type for PNET determine survival. Report from the Childrens Cancer Group CCG‐921. Med Pediatr Oncol 25: 238. [Google Scholar]
  • 159. Zimmerman FA, Bilaniuk LT, Pahlajani H. (1978) Spectrum of medulloblastomas demonstrated by computed tomograph. Radiology 126: 137–141. [DOI] [PubMed] [Google Scholar]
  • 160. Zimmerman RA, Bilanluk LT, Rebsamen S. (1992) Magnetic resonance imaging of pediatric Posterior fossa tumors. Pediatr Neursourg 18: 58–64. [DOI] [PubMed] [Google Scholar]
  • 161. Zimmerman RA, Bilaniuk LT, Sutton LN, Phillips P. Systematic evaluation of spinal PNET dissemination by gadolinium enhanced MR. Presented at 5th International Symposilum on Pediatric Nuro‐Oncology, June 1993.
  • 162. ZuRein GM, Varakis JN (1979) Perinata induction of medulloblastomas in Syrian golden hamster by a human poloyma virus (JC). Natl Cancer Inst Monogr 51: 205–208. [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES